Author: KCCure

COVID-19 Vaccine – Kidney Cancer Patient Survey

As a follow-up to our survey from March 2020, we sought to get updated views from our patient communities regarding concerns and anxieties related to the COVID-19 virus as well as to get additional thoughts about the vaccine roll-out. Similarly to our March survey, over 500 patients participated. Eighty-seven percent of patients were from the United States. People from 47 states participated. The ...

In Remembrance 2020

This year, more than 150,000 people died worldwide from kidney cancer. This video represents just a fraction of the toll that this disease has taken. Please take a moment to honor and remember those that we lost this year.

Voice of Kidney Cancer – Jeff Zdanowski

I had a goal to be in better shape and good health for my 50th birthday and was feeling very good about myself after receiving positive feedback from my annual physical. Unfortunately, this feeling didn’t last very long. Within the next month after my birthday, I had fallen a couple of times from blacking out after standing up too quickly. One morning I found myself not physically able to stand up...

Kidney Cancer Drug Names

Fear of Cancer Recurrence – and why it matters so much

Seventy-five percent of patients will be diagnosed with localized disease – cancer that is confined to the kidney. For most of these patients, surgery will be curative. Because of that fact, few resources exist to support these patients. The assumption is that they are “cured” and no longer need additional care. They are “lucky.” The problem with this logic is that 20...

KCCure All-Star – Dr. Ulka Vaishampayan

Finding a kidney cancer specialist can be daunting. KCCure Patient Communities offer excellent opportunities to get recommendations from others. Learn more at KCCure.

Putting the Tie Back in July!

Every July, we hold our month long, “No Tie July” fundraising effort to raise money for kidney cancer. But this year is different. This year many of us wish we could wear a tie. Offices and workplaces around the world remain closed. And even once workplaces reopen, many people won’t have jobs to go back to. We know that everyone is struggling in this uncertain environment. If you can make a donati...

Voice of Kidney Cancer – Jeanette Bartram

I feel led to share my dad’s story. I hope it will give hope and be helpful to others. On June 19th, 2019 my dad, who had recently retired, was in his garage moving things around when he tripped over a cord and landed on his right shoulder. My mom immediately took him to the emergency room where they did an x-ray and found he had a spot (bone met) on the shoulder he broke and one bone met on...

Treatment Advances in RCC

April 20, 2020 Today, Exelixis and BMS announced positive results from a Phase 3 trial combining Cabometyx (cabozantinib) with Opdivo (nivolumab) as a first-line treatment in advanced RCC. What does that mean for patients? In trial, the combination of Opdivo+Cabometyx showed superiority in both tumor control and overall survival versus patients who were treated with Sutent (sunitinib) alone. More ...

Lost Password

Register

Subscribe for updates!